SDC4 and ovarian cancer: Furthermore, we discovered that syndecan 4 (SDC4) may act as an important modulator within the HGSOC TME. To validate these findings, experimental validation was performed using ovarian cancer cell lines (OVCAR3 and SKOV3), where quantitative real-time PCR (qRT-PCR) confirmed the upregulation of SDC4.